Skip to main content
Top
Published in: Clinical and Translational Oncology 1/2013

01-01-2013 | Research Article

Tumor bed segmentation: first step for partial breast irradiation

Authors: Amparo González Sanchis, Luis Brualla González, Carlos Fuster Diana, Jose Carlos Gordo Partearroyo, Andres Garcia-Vilanova Comas, Jose Luis Lopez Torrecilla, Joan Roselló Ferrando

Published in: Clinical and Translational Oncology | Issue 1/2013

Login to get access

Abstract

Introduction

In breast IMRT simultaneous integrated boost (SIB) treatment and accelerated partial breast irradiation (APBI), proper delineation of the tumor bed is necessary. Conservative oncoplastic surgery causes changes in peritumoral breast tissue that complicates locating the site of the tumor. Nevertheless, there are still centers that do not use surgical clips to delineate the site. This study aims to show how the lack of clips affects the techniques of SIB and APBI in terms of dose distribution and safety margins in the tumor bed.

Materials and methods

On 30 patients, the defining of the tumor bed obtained from the pre-surgery CT scan to that outlined on the basis of clips on the post-surgery CT was compared. Tumor bed deviation from the original tumor site was quantified. In addition, the margins to the original tumor site necessary to guarantee the coverage of the tumor bed were calculated.

Results

Variations were detected in the distances between geometric centers of the PTV (minimum 0.5–maximum 3 cm). The maximum margin necessary to include the entire tumor bed was 4.5 cm. Lesions located in the upper outer quadrant required the widest margins. If margins are not added, the tumor bed volume defined with clips will be underdosed.

Conclusions

The definition of the tumor bed based on studies before surgery does not have the necessary accuracy. Clips need to be placed in the surgical bed to identify the changes occurring after the restorative mammoplasty. Without clips, SIB and APBI are not safe.
Literature
1.
go back to reference Clarke M, Collins R, Early Breast Cancer Trialists’ Collaborative Group (2005) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366:2087–2106PubMed Clarke M, Collins R, Early Breast Cancer Trialists’ Collaborative Group (2005) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366:2087–2106PubMed
2.
go back to reference Fisher B, Anderson S, Bryant J et al (2002) Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347:1233–1241PubMedCrossRef Fisher B, Anderson S, Bryant J et al (2002) Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347:1233–1241PubMedCrossRef
3.
go back to reference Bartelink H, Horiot JC, Poortmans P et al (2001) Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med 345:1378–1387PubMedCrossRef Bartelink H, Horiot JC, Poortmans P et al (2001) Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med 345:1378–1387PubMedCrossRef
4.
go back to reference Bartelink H, Horiot JC, Poortmans PM et al (2007) Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881–10882 trial. J Clin Oncol 25:3259–3265PubMedCrossRef Bartelink H, Horiot JC, Poortmans PM et al (2007) Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881–10882 trial. J Clin Oncol 25:3259–3265PubMedCrossRef
5.
go back to reference Romestaing P, Lehingue Y, Carrie C et al (1997) Role of a 10-Gy boost in the conservative treatment of early breast cancer: results of a randomized clinical trial in Lyon, France. J Clin Oncol 15:963–968PubMed Romestaing P, Lehingue Y, Carrie C et al (1997) Role of a 10-Gy boost in the conservative treatment of early breast cancer: results of a randomized clinical trial in Lyon, France. J Clin Oncol 15:963–968PubMed
6.
go back to reference Kirova YM, Fournier-Bidoz N, Servois V et al (2008) How to boost the breast tumor bed? A multidisciplinary approach in eight steps. Int J Radiat Oncol Biol Phys 72:494–500PubMedCrossRef Kirova YM, Fournier-Bidoz N, Servois V et al (2008) How to boost the breast tumor bed? A multidisciplinary approach in eight steps. Int J Radiat Oncol Biol Phys 72:494–500PubMedCrossRef
7.
go back to reference Hurkmans CW, Meijer GJ, van Vliet-Vroegindeweij C et al (2006) High-dose simultaneously integrated breast boost using intensity-modulated radiotherapy and inverse optimization. Int J Radiat Oncol Biol Phys 66:923–930PubMedCrossRef Hurkmans CW, Meijer GJ, van Vliet-Vroegindeweij C et al (2006) High-dose simultaneously integrated breast boost using intensity-modulated radiotherapy and inverse optimization. Int J Radiat Oncol Biol Phys 66:923–930PubMedCrossRef
8.
go back to reference Singla R, King S, Albuquerque K et al (2006) Simultaneous-integrated boost intensity-modulated radiation therapy (SIBIMRT) in the treatment of early-stage left-sided breast carcinoma. Med Dosim 31:190–196PubMedCrossRef Singla R, King S, Albuquerque K et al (2006) Simultaneous-integrated boost intensity-modulated radiation therapy (SIBIMRT) in the treatment of early-stage left-sided breast carcinoma. Med Dosim 31:190–196PubMedCrossRef
9.
go back to reference Van der Laan HP, Dolsma WV, Maduro JH et al (2007) Three-dimensional conformal simultaneously integrated boost technique for breast-conserving radiotherapy. Int J Radiat Oncol Biol Phys 68:1018–1023PubMedCrossRef Van der Laan HP, Dolsma WV, Maduro JH et al (2007) Three-dimensional conformal simultaneously integrated boost technique for breast-conserving radiotherapy. Int J Radiat Oncol Biol Phys 68:1018–1023PubMedCrossRef
10.
go back to reference Benitez PR, Keisch ME, Vicini F et al (2007) Five-year results: the initial clinical trial of MammoSite balloon brachytherapy for partial breast irradiation in early-stage breast cancer. Am J Surg 194:4556–4562CrossRef Benitez PR, Keisch ME, Vicini F et al (2007) Five-year results: the initial clinical trial of MammoSite balloon brachytherapy for partial breast irradiation in early-stage breast cancer. Am J Surg 194:4556–4562CrossRef
11.
go back to reference Polgar C, Major T, Fodor J et al (2004) High-dose-rate brachytherapy alone versus whole breast radiotherapy with or without tumor bed boost after breast-conserving surgery: seven-year results of a comparative study. Int J Radiat Oncol Biol Phys 60:1173–1181PubMedCrossRef Polgar C, Major T, Fodor J et al (2004) High-dose-rate brachytherapy alone versus whole breast radiotherapy with or without tumor bed boost after breast-conserving surgery: seven-year results of a comparative study. Int J Radiat Oncol Biol Phys 60:1173–1181PubMedCrossRef
12.
go back to reference Dodwell DJ, Dyker K, Brown J et al (2005) A randomized study of whole-breast vs. tumour-bed irradiation after local excision and axillary dissection for early breast cancer. Clin Oncol 17:618–622CrossRef Dodwell DJ, Dyker K, Brown J et al (2005) A randomized study of whole-breast vs. tumour-bed irradiation after local excision and axillary dissection for early breast cancer. Clin Oncol 17:618–622CrossRef
13.
go back to reference Polgar C, Fodor J, Major T et al (2007) Breast-conserving treatment with partial or whole breast irradiation for low-risk invasive breast carcinoma—5-year results of a randomized trial. Int J Radiat Oncol Biol Phys 69:694–702PubMedCrossRef Polgar C, Fodor J, Major T et al (2007) Breast-conserving treatment with partial or whole breast irradiation for low-risk invasive breast carcinoma—5-year results of a randomized trial. Int J Radiat Oncol Biol Phys 69:694–702PubMedCrossRef
14.
go back to reference Langen KM, Buchholz DJ, Burch DR et al (2008) Investigation of accelerated partial breast patient alignment and treatment with helical tomotherapy unit. Int J Radiat Oncol Biol Phys 70:1272–1280PubMedCrossRef Langen KM, Buchholz DJ, Burch DR et al (2008) Investigation of accelerated partial breast patient alignment and treatment with helical tomotherapy unit. Int J Radiat Oncol Biol Phys 70:1272–1280PubMedCrossRef
15.
go back to reference Leonard CE, Carter D, Kercher J et al (2007) A prospective trial of accelerated partial breast intensity modulated radiotherapy. Int J Radiat Oncol Biol Phys 67:1291–1298PubMedCrossRef Leonard CE, Carter D, Kercher J et al (2007) A prospective trial of accelerated partial breast intensity modulated radiotherapy. Int J Radiat Oncol Biol Phys 67:1291–1298PubMedCrossRef
16.
go back to reference Smith BD, Arthur DW, Buchholz TA et al (2009) Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). Int J Radiat Oncol Biol Phys 74:987–1001PubMedCrossRef Smith BD, Arthur DW, Buchholz TA et al (2009) Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). Int J Radiat Oncol Biol Phys 74:987–1001PubMedCrossRef
17.
go back to reference Bedwinek J (1993) Breast conserving surgery and irradiation: the importance of demarcating the excision cavity with surgical clips. Int J Radiat Oncol Biol Phys 26:675–679PubMedCrossRef Bedwinek J (1993) Breast conserving surgery and irradiation: the importance of demarcating the excision cavity with surgical clips. Int J Radiat Oncol Biol Phys 26:675–679PubMedCrossRef
18.
go back to reference Kokubo M, Mitsumori M, Yamamoto C et al (2001) Impact of boost irradiation with surgically placed radiopaque clips on local control in breast-conserving therapy. Breast Cancer 8:222–228PubMedCrossRef Kokubo M, Mitsumori M, Yamamoto C et al (2001) Impact of boost irradiation with surgically placed radiopaque clips on local control in breast-conserving therapy. Breast Cancer 8:222–228PubMedCrossRef
19.
go back to reference Oh JL, Nguyen G, Whitman GJ et al (2007) Placement of radiopaque clips for tumor localization in patients undergoing neoadjuvant chemotherapy and breast conserving therapy. Cancer 110:2420–2427PubMedCrossRef Oh JL, Nguyen G, Whitman GJ et al (2007) Placement of radiopaque clips for tumor localization in patients undergoing neoadjuvant chemotherapy and breast conserving therapy. Cancer 110:2420–2427PubMedCrossRef
20.
go back to reference Penninkhof J, Quint S, De Boer H et al (2009) Surgical clips for position verification and correction of non-rigid breast tissue in simultaneously integrated boost (SIB) treatments. Radiother Oncol 90:110–115PubMedCrossRef Penninkhof J, Quint S, De Boer H et al (2009) Surgical clips for position verification and correction of non-rigid breast tissue in simultaneously integrated boost (SIB) treatments. Radiother Oncol 90:110–115PubMedCrossRef
Metadata
Title
Tumor bed segmentation: first step for partial breast irradiation
Authors
Amparo González Sanchis
Luis Brualla González
Carlos Fuster Diana
Jose Carlos Gordo Partearroyo
Andres Garcia-Vilanova Comas
Jose Luis Lopez Torrecilla
Joan Roselló Ferrando
Publication date
01-01-2013
Publisher
Springer Milan
Published in
Clinical and Translational Oncology / Issue 1/2013
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-012-0884-1

Other articles of this Issue 1/2013

Clinical and Translational Oncology 1/2013 Go to the issue

Acknowledgements to Referees

Acknowledgements to Referees 2012

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine